Our recently published study on adherence to lipid-lowering drugs was featured in a newspaper article in Dagens Medisin. Our study tracks all patients in Norway who initiated treatment with proprotein convertase subtilisin/kexin type 9 monoclonal antibodies (PCSK9 mAbs) from 2015 to 2023.
On behalf of the Police Directorate, Oslo Economics and KPMG conducted an evaluation of the Norwegian police’s use of financial intelligence.
Oslo Economics, in collaboration with Sverre Kittelsen (Frisch Centre), Kjartan Sarheim Anthun (SINTEF) and Jon Magnussen (NTNU), has calculated the marginal costs associated with increasing the activity levels in the Norwegian specialist health service. The study is part of the foundation for the Norwegian government’s recently announced healthcare plan and has been conducted on the behalf of the Ministry of Health and Care Services.
Oslo Economics has recently acted as economic expert in a dispute about earn-out payments connected to an alleged breach of a best-effort clause in a shares purchase agreement.
Since April 2018, a total of 17 general practitioner (GP) offices have participated in a pilot project with primary health care teams (PHT) and two alternative financing schemes. Results from the pilot study indicate that GP offices experience that PHT offer new solutions to their challenges, and further that most patients were satisfied with the follow-up and would like to continue with nurse consultations
